Around the Practice

Experts from the Cleveland Clinic provide an overview of recent updates in the treatment landscape for patients with multiple myeloma, discussing patient cases, clinical trials, and improving outcomes for patients.

Centering discussion on several patient cases, expert oncologists work together to review the evolving treatment landscape of HER2+ breast cancer with a focus on brain metastases.

A panel of esteemed breast cancer experts discuss the latest research in the treatment of HER2+ metastatic breast cancer with brain metastases and how data updates would affect treatment-decision making in three patient cases.

A panel of expert oncologists reviews key updates from recent meetings regarding the testing and treatment of metastatic colorectal cancer in the context of real-world clinical practice.

Elle Charnisky, a patient with stage IV HER2+ metastatic colorectal cancer (mCRC), joins a panel of healthcare professionals to discuss how HER2 alternations are detected and how patients with HER2+ mCRC are optimally treated to improve outcomes.

Centering discussion on several patient cases, expert oncologists review key data updates in the multiple myeloma treatment landscape from IMS 2022 and other recent meetings.

A panel of experts reviews key data updates in multiple myeloma from IMS [International Myeloma Society Annual Meeting] 2022 and other recent meetings and discusses how they can be best applied in clinical practice.

Centering discussion around three patient cases of multiple myeloma, expert oncologists from the University of Pennsylvania review the optimal selection and application of treatment.

A panel of experts discusses the treatment approaches to three clinical cases of multiple myeloma in the context of data presented at recent meetings and reviews how it can be applied to daily clinical practice.

Centering discussion on clinical scenarios of urothelial carcinoma, expert oncologists review recent data and discuss how patient care is evolving.

A panel of experts in multiple myeloma discusses recent data updates from IMS 2022 [International Myeloma Society Annual Meeting] and how it influences treatment strategies in clinical practice.

Drs Andre Goy, Lori Leslie, and Andrew Ip, expert lymphoma physicians from the John Theurer Cancer Center at Hackensack University Medical Center, discuss recent updates on the role of CAR T-cell therapy in lymphoma treatment.

Centering discussion on two clinical scenarios, expert panelists review recent evolutions in the field of graft vs host disease management and provide their perspective on optimal treatment strategies.

Expert oncologists review key studies in the m CSPC treatment landscape and discuss how evidence can be applied to clinical practice to improve patient outcomes.

Centering discussion on patient scenarios, expert oncologists define the current and future use of MRD and ctDNA in both colorectal and breast cancer management.

A panel of experts in breast oncology builds a lively discussion on evolving approaches in the management of HER2+ metastatic breast cancer, including key considerations for the treatment of patients with brain metastases.

A panel of oncologists discuss recent updates in the management of patients with myelofibrosis and share insight into their strategies for two case scenarios.

A panel of experts review real-world clinical scenarios to highlight recent advances in the management of multiple myeloma.

Expert panelists review key data from recent meetings on the management of multiple myeloma and consider how these can be applied to clinical practice.

A panel of experts review two patient cases to elucidate data in the adjuvant setting of non–small cell lung cancer.

A panel of experts from Emory University review several key data updates in multiple myeloma from recent meetings and discuss how the data can be applied to clinical practice to improve patient outcomes.

Drs. Sara Hurvitz, Stefania Maraka, and Ruta Rao discuss the evolving landscape of metastatic HER2+ breast cancer, highlighting recent clinical trials and the management of patients with brain metastases.

Expert panelists focus on a patient profile of metastatic urothelial cancer, discuss strategies and challenges for maintenance therapy, and comment on how recent clinical trial data presented at the 2022 ASCO Genitourinary Cancers Symposium may impact clinical practice for patients with the disease.

A panel of experts in stem cell transplant and cellular immunotherapy builds a lively discussion on current and emerging treatment options for the management of acute and chronic graft versus host disease.

Expert panelists center discussion around two patient cases to review use of newer anti-androgen deprivation therapy in the management of prostate cancer.

Experts center their discussion on patient profiles to highlight recent advances in the treatment of renal cell carcinoma and how they apply evidence from research into clinical practice to optimize patient outcomes.

A panel of experts provides a discussion on treatments for newly diagnosed transplant eligible, transplant ineligible, and relapsed multiple myeloma, and how recent clinical trial data presented at ASH 2021 can be applied to clinical practice.

Various healthcare professionals join to discuss the management of a patient diagnosed with HER2-positive breast cancer and consider how to best approach the patient with newer treatment strategies through her continuum of care.

Recommendations for introducing novel therapies into earlier lines of therapy for patients with transplant-eligible and transplant-ineligible multiple myeloma.

Expert panelists follow a patient case to discuss locally advanced and metastatic urothelial carcinoma with a focus on frontline and maintenance therapy.